The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients
Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
In this study of patients with moderate traumatic brain injury with frontal brain contusions
patients will be randomized to treatment with a single dose of either D-cycloserine or
placebo given 48-72 hours after injury.
Patients will undergo intensive neurocognitive testing at 3 and 6 months after injury to
assess whether treatment with a single dose of D-cycloserine improves cognitive outcome after
moderate brain injury.